Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on October 6, 2026

2 hours ago

Porch Light Health Awarded $6.6 Million Through Colorado Rural Health Transformation Program

Indeterminate GlobeNewswire

2 hours ago

TSC Life Receives FDA Clearance for Mistral-Air® MA1400 Forced Air Warming System

Indeterminate GlobeNewswire

2 hours ago

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

2 hours ago

Cerenome Launches CNSide® CSF Molecular Profile Tests

Indeterminate GlobeNewswire

2 hours ago

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

Indeterminate GlobeNewswire

3 hours ago

ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

Indeterminate GlobeNewswire

3 hours ago

Zenas BioPharma to Host Virtual R&D Event

Indeterminate GlobeNewswire

3 hours ago

Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate

Indeterminate GlobeNewswire

3 hours ago

Why Do You Keep Gaining Weight Back After Losing It

Indeterminate GlobeNewswire

3 hours ago

F2G Announces Abstracts Accepted for Oral and Poster Presentation at IDWeek 2026

Indeterminate GlobeNewswire

3 hours ago

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Indeterminate GlobeNewswire

3 hours ago

Shopify to Announce Third-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)

Indeterminate GlobeNewswire

3 hours ago

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

Indeterminate GlobeNewswire

3 hours ago

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain

Indeterminate GlobeNewswire

3 hours ago

MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

Indeterminate GlobeNewswire

3 hours ago

Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update

Indeterminate GlobeNewswire

3 hours ago

Nox Peptides Announces Launch of GHK-Cu and Wolverine Stack for Canadian Research Market

Indeterminate GlobeNewswire

3 hours ago

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Indeterminate GlobeNewswire